Evidence map›Paper›PMID 29977712›Full record

ArticleBeilstein journal of nanotechnology2018

A visible-light-controlled platform for prolonged drug release based on Ag-doped TiO

Caihong Liang, Jiang Wen, Xiaoming Liao

Abstract read
In one paragraph

Article in Beilstein journal of nanotechnology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Caihong LiangCollege of Materials Science and Engineering, Sichuan University, Chengdu, Sichuan 610065, China.
Jiang WenCollege of Materials Science and Engineering, Sichuan University, Chengdu, Sichuan 610065, China.
Xiaoming LiaoCollege of Materials Science and Engineering, Sichuan University, Chengdu, Sichuan 610065, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, a visible-light-controlled drug release platform was constructed for localized and prolonged drug release based on two-layer titania nanotubes (TNTs) fabricated using by an in situ voltage up-anodization process. The visible-light photocatalytic activity is improved by loading Ag onto the TNTs by NaBH

Indexed as

Ag dopingdrug deliveryhydrophobic layerprolonged drug releaseTiO2 nanotubesvisible-light-controlled release

Identifiers

PMID29977712
PMCPMC6009292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.